UpFront
-
J&J vaccine and blood clots: A risk, if it exists, is tiny
On April 13, US federal health regulators recommended a pause in the use of Johnson & Johnson's Covid-19 vaccine while they investigated six reports of blood clots in women ages 18 to 48
-
What's good about tech bubbles
Unlike the housing market bubble, technology bubbles aren't typically inflated by borrowed money that can cause cascading effects
-
It's time to rethink the Olympics
The Tokyo Games could end up being a three-week superspreader event that leads to illness and death across Japan and far beyond
-
Inside India Quotient, the VC firm that won big with ShareChat
Founding partners Madhukar Sinha and Anand Lunia are now raising their fourth fund to invest in Indian startups, having backed a handful of winners whose potential was not so apparent to many early on
-
The evolution of edtech: Much more than a union of education and technology
Forbes India's special package this fortnight is on education—online and offline, school and home, urban and rural, real and fake. Plus, is a duopoly emerging in edtech, and a lot more
-
Time spent with yourself is the greatest gift: Manish Malhotra
Bollywood's ace designer, Manish Malhotra, takes us on a journey from his filmy childhood to defining the style of entertainment industry. He also reflects on how 'being yourself' is the latest trend not just in fashion but also life
-
Biden backs Taiwan, but some call for a clearer warning to China
As China's power and ambition grow, and Beijing assesses Washington to be weakened and distracted, a debate is underway whether the United States should make a clearer commitment to the island's defence
-
Is this the future of face masks?
Called Xupermask and made of silicone with athletic mesh fabric on the sides, it comes with three dual-speed fans, a filtration system, as well as noise-cancelling headphones, LED lights for nighttime, a rechargeable battery and bluetooth capability
-
Ten interesting things we read this week
Some of the most fascinating topics covered this week are: Economics (Could index funds be 'worse than Marxism'?), Stock Market (Premchand Roychand: Mumbai's original share king), Technology (Life after the pandemic), Careers (Programmer to CEO in 3 years), Strategy (Why drug makers are spending big on data), and Investing (The greatest show on earth).
-
India's unicorn party is just getting started
It's pouring unicorns in India...out of 10 born so far this year, six sprung to life in April. The funding bus is set to get more crowded
-
Covid-19 second wave: Why are hospitals falling short of ventilators, again?
Inventories lying idle with manufacturers, shortage of trained staff are some of the reasons for the shortfall, despite the unprecedented surge in ventilators being made in India last year